Results 221 to 230 of about 19,796 (310)

Combining Treatment of Acute Malnutrition With Integrated Community Case Management: A Cluster‐Randomised Controlled Trial (SETiPlus)

open access: yesMaternal &Child Nutrition, Volume 22, Issue 3, July 2026.
ABSTRACT Achieving good treatment coverage and outcomes for acutely malnourished children is challenging in resource limited and remote settings. Inclusion of treatment within integrated community case management (iCCM) programmes has shown promise, but evidence is limited. We conducted a cluster randomised controlled trial in rural villages within the
Gael Cronin   +11 more
wiley   +1 more source

The EBNA‐1 Conundrum: Does Epstein–Barr Virus Invoke Autoimmune Pathology in a Population Subset by Poorly Purine‐Loading Its Major Latency‐Maintaining Transcript?

open access: yesScandinavian Journal of Immunology, Volume 104, Issue 1, July 2026.
ABSTRACT Viruses activate host defences by alerting interferon and other alarms. Viruses seeking latency must curtail this. Infected subjects would then have minimal immune system activation and remain healthy. However, a minority cannot prevent emergence of associated diseases.
Donald R. Forsdyke
wiley   +1 more source

Total Synthesis and Antimalarial Studies of Caelestines A–C

open access: yesChemMedChem, Volume 21, Issue 11, 15 June 2026.
Total synthesis of caelestines A–C (alkaloids from the Australian ascidian, Aplidium caelestis) was accomplished, constituting the first synthesis of caelestines B and C. Caelestines A–C, with five other novel quinolones, were assessed against Plasmodium falciparum 3D7 and Dd2. Caelestine B was found to be a selective antimalarial alkaloid. Caelestines
Henry S. T. Smith   +3 more
wiley   +1 more source

Treatment of uncomplicated malaria in Guinea-Bissau

open access: yes, 2006
Treatment of malaria has become increasingly difficult due to high levels of resistance to the cheap and commonly used antimalarials. In Guinea-Bissau, the first line drug is chloroquine (CQ), the second line drug is sulfadoxine-pyrimethamine (S/P), and the third line therapy is quinine (QU). During the last ten years we have studied these drugs in the
openaire   +3 more sources

A systematic review and meta-analysis of blood level of MCP-1/CCL-2 in severe and uncomplicated malaria. [PDF]

open access: yesSci Rep
Kotepui M   +6 more
europepmc   +1 more source

Natural Products as Geroprotective Modulators in Diabetic Nephropathy: A Mechanistic Framework Integrating Aging Hallmarks and the AMPK–SIRT1–Nrf2 Axis

open access: yesAging and Cancer, Volume 7, Issue 2, Page 52-66, June 2026.
Natural products target the aging kidney in diabetic nephropathy by restoring the AMPK–SIRT1–Nrf2 axis, reducing oxidative stress, inflammation, fibrosis, and cellular senescence while enhancing mitochondrial biogenesis and antioxidant defenses.
Sherif Hamidu   +8 more
wiley   +1 more source

The use of the WHO criteria to detect severe malaria among patients clinically diagnosed with uncomplicated malaria. [PDF]

open access: yesPLOS Glob Public Health
Aninagyei E   +7 more
europepmc   +1 more source

Microstructural Evidence for Early Childhood Stress in a Community in Transition at Hisban, Jordan

open access: yesAmerican Journal of Biological Anthropology, Volume 190, Issue 2, June 2026.
ABSTRACT Objectives Identification of stress across infancy and childhood can reflect maternal and environmental influences on early life health. In the 19th century community of Hisban, many infants died before 2 years of age with evidence of metabolic disease, including rickets, that likely ties with maternal health.
Kristina Cockerille   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy